Literature DB >> 6906160

[The effect of timolol and dipivalyl-epinephrine in the treatment of the elevated intraocular pressure (author's transl)].

M Ober, A Scharrer.   

Abstract

Twenty-seven patients with ocular hypertension or open angle glaucoma were tested to see if, and to what extent, timolol and dipivalyl-epinephrine produced a supplementary reduction of intraocular pressure. In a shortterm study, 14 patients were tested with timolol (0.1%) and dipivalyl-epinephrine (0.25%). Simultaneous application of both substances produced a statistically more significant reduction of intraocular pressure than either timolol (0.1%) or dipivalyl-epinephrine (0.25%) alone. In 13 patients a comparison was made between patients who received both timolol (0.25%) and dipivalyl-epinephrine (0.1%) bis x and patients who received only timolol (0.25%) bis x over a period of 6, 9 and 12 weeks. Both substances used in combination produced a statistically more significant reduction in intraocular pressure than timolol (0.25%) bis x alone. The simultaneous application of an alpha and beta-adrenergic agonist and beta-adrenergic antagonist is not contradictory. The results are discussed on the basis of the mode of action of the applied substances.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6906160     DOI: 10.1007/bf00417550

Source DB:  PubMed          Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol        ISSN: 0065-6100


  25 in total

1.  Regional differences in the fine structure of the ciliary epithelium related to accommodation.

Authors:  M Ober; J W Rohen
Journal:  Invest Ophthalmol Vis Sci       Date:  1979-07       Impact factor: 4.799

2.  Comparison of the effects of timolol and other adrenergic agents on intraocular pressure in the rabbit.

Authors:  P Vareilles; D Silverstone; B Plazonnet; J C Le Douarec; M L Sears; C A Stone
Journal:  Invest Ophthalmol Vis Sci       Date:  1977-11       Impact factor: 4.799

3.  Beta-adrenergic responses in the eyes of rabbits, primates, and man.

Authors:  M E Langham; E Diggs
Journal:  Exp Eye Res       Date:  1974-09       Impact factor: 3.467

4.  Timolol plus maximum-tolerated antiglaucoma therapy.

Authors:  T J Zimmerman; J E Gillespie; M A Kass; M E Yablonski; B Becker
Journal:  Arch Ophthalmol       Date:  1979-02

5.  Cardiac effects of topical timolol.

Authors:  N A Britman
Journal:  N Engl J Med       Date:  1979-03-08       Impact factor: 91.245

Review 6.  Experimental studies on the mechanism of action of timolol.

Authors:  A H Neufeld
Journal:  Surv Ophthalmol       Date:  1979 May-Jun       Impact factor: 6.048

7.  [Clinical experiences with timolol eye drops].

Authors:  M Ober; H Meythaler; K Porkert
Journal:  Ophthalmologica       Date:  1979       Impact factor: 3.250

8.  Timolol, dose response and duration of action.

Authors:  T J Zimmerman; H E Kaufman
Journal:  Arch Ophthalmol       Date:  1977-04

9.  [The effect of timolol eye drops on the intraocular pressure in simple glaucoma (author's transl)].

Authors:  G K Krieglstein
Journal:  Klin Monbl Augenheilkd       Date:  1978-05       Impact factor: 0.700

10.  Absence of an effect of timolol on the pupil.

Authors:  S H Johnson; R F Brubaker; J C Trautman
Journal:  Invest Ophthalmol Vis Sci       Date:  1978-09       Impact factor: 4.799

View more
  4 in total

1.  Dose-related interaction between timolol and adrenaline.

Authors:  A Ohrström
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1981

2.  Timolol treatment of chronic open-angle glaucoma and ocular hypertension. A 2.5-year multicenter study.

Authors:  P J Airaksinen; O Valle; K K Takki; A Klemetti
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1982       Impact factor: 3.117

3.  A single-blind randomised trial comparing adrenaline 1.0% with dipivalyl epinephrine (propine) 0.1% in the treatment of open-angle glaucoma and ocular hypertension.

Authors:  K B Mills; N A Jacobs
Journal:  Br J Ophthalmol       Date:  1988-06       Impact factor: 4.638

4.  Dose response of oral timolol combined with adrenaline.

Authors:  A Ohrström
Journal:  Br J Ophthalmol       Date:  1982-04       Impact factor: 4.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.